https://www.pharmanow.live/latest-news/alembic-pharma-fda-approval-generic-ciprodex-otic-suspension 2026-10-17T22:36:23+05:30 Pharma Now en 2026-10-17T00:00:00+05:30 Alembic Pharma Gains FDA Approval for Generic Ciprodex Otic Suspension in U.S. Market Alembic https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/71231680-c20d-4ea7-a2d6-1f1b8711353c/a83fb056-ac2b-44dd-81b0-9f659ee70494.png https://www.pharmanow.live/latest-news/viatris-fda-approval-ryzumvi-presbyopia-phentolamine-ophthalmic 2026-10-17T22:35:28+05:30 Pharma Now en 2026-10-17T00:00:00+05:30 Viatris Gains FDA Approval for RYZUMVI in Presbyopia, Expanding Phentolamine Ophthalmic Indications Viatris https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://newsroom.viatris.com/file.php/181193/Refreshed_Viatris_Logo_thumb.png?thumbnail=144 https://www.pharmanow.live/latest-news/analytik-jena-opens-96-million-german-facilities-laboratory-instrumentation 2026-10-17T11:17:42+05:30 Pharma Now en 2026-10-16T00:00:00+05:30 Analytik Jena Opens €96M German Facilities to Expand Lab Capacity Analytik https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/analytik-jena-96-million-german-lab-facilities-202620261017111735.webp https://www.pharmanow.live/latest-news/fda-cder-exclusivity-board-nce-biologic-exclusivity-rulings 2026-10-17T11:12:29+05:30 Pharma Now en 2026-10-16T00:00:00+05:30 FDA Creates CDER Exclusivity Board to Standardize Drug Rulings FDA https://www.pharmanow.live/latest-news/alcon-fda-approval-brytly-nonprescription-apraclonidine-eye-drop 2026-10-17T11:07:35+05:30 Pharma Now en 2026-10-16T00:00:00+05:30 Alcon Wins FDA Approval for Brytly Nonprescription Eye Drops Alcon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/alcon-brytly-fda-approval-nonprescription-apraclonidine-eye-drops-202620261017110722.webp https://www.pharmanow.live/latest-news/fda-counterfeit-eye-drops-bacterial-contamination-dlc-laboratories-promex 2026-10-17T11:01:52+05:30 Pharma Now en 2026-10-16T00:00:00+05:30 FDA Warns of Bacterial Contamination in Counterfeit Eye Drops FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-counterfeit-eye-drops-bacterial-contamination-202620261017110148.webp https://www.pharmanow.live/latest-news/ema-chmp-october-2026-meeting-highlights-orforglipron-biosimilars 2026-10-17T10:56:18+05:30 Pharma Now en 2026-10-16T00:00:00+05:30 EMA CHMP Recommends Six Medicines for Approval in October 2026 EMA CHMP https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/ema-chmp-october-2026-orforglipron-biosimilar-approvals-202620261017105605.webp https://www.pharmanow.live/latest-news/adial-pharmaceuticals-appoints-david-rubenstein-chief-scientist-at177-ulcerative-colitis 2026-10-17T10:49:13+05:30 Pharma Now en 2026-10-16T00:00:00+05:30 Adial Appoints David Rubenstein as Chief Scientist for AT177 Adial https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/adial-pharmaceuticals-david-rubenstein-chief-scientist-at177-202620261017104704.webp